

Other version: http://stroke.ahajournals.org/content/47/5/1180
![]() |
TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke |
|
Authors | ![]() | |
Published in | Stroke. 2016, vol. 47, no. 5, p. 1180-6 | |
Abstract | Clopidogrel is one of the most used antiplatelet drugs in patients with cardiovascular disease. However, 16% to 50% of patients have a high on-clopidogrel platelet reactivity and an increased risk of ischemic events. The pathogenesis of high on-treatment platelet reactivity in patients with stroke is only partially explained by genetic variations. This study aims to find differentially methylated sites across the genome associated with vascular recurrence in ischemic stroke patients treated with clopidogrel. | |
Keywords | Aspirin — Clopidogrel — Methylation — Stroke — Vascular resistance | |
Identifiers | PMID: 27026631 | |
Full text |
![]() ![]() Other version: http://stroke.ahajournals.org/content/47/5/1180 |
|
Structures | ||
Research group | Geneva Platelet Group (13) | |
Citation (ISO format) | GALLEGO-FABREGA, Cristina et al. TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke. In: Stroke, 2016, vol. 47, n° 5, p. 1180-6. https://archive-ouverte.unige.ch/unige:84481 |